Vsaar Pharma Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Voglizen GM 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Voglizen GM 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglizen GM 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglizen GM 2mg/500mg/0.2mg Tablet.
Voglizen GM 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglizen GM 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Voglizen GM 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Voglizen GM 2mg/500mg/0.2mg Tablet is a combination medication consisting of Glimepiride, Metformin, and Voglibose. It works by improving blood glucose levels in adults with type 2 diabetes when taken along with proper diet and regular exercise. Glimepiride increases insulin release from the pancreas, while Metformin lowers liver glucose production and improves insulin sensitivity. Voglibose inhibits alpha-glucosidase, reducing postprandial glucose levels.
Common side effects associated with Voglizen GM 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
The use of Voglizen GM 2mg/500mg/0.2mg Tablet should be avoided in patients with known allergy to any component or excipient, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, it is not recommended to take alcohol with Voglizen GM 2mg/500mg/0.2mg Tablet as it may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, taking Voglizen GM 2mg/500mg/0.2mg Tablet can lead to hypoglycemia (low blood sugar), which may be more likely if you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medications along with it. Regular monitoring of blood glucose levels is essential.
Store the medication in its original packet or container, tightly closed, according to the instructions on the pack or label. Dispose of unused medicine properly, ensuring it is not consumed by pets, children, or other individuals.